Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 4, 2012, Pages 940-949

  Doan, Ngoc Duc ^a,c   Chatenet, David ^a,c   Létourneau, Myriam ^a,c   Vaudry, Hubert ^b,c   Vaudry, David ^b,c   Fournier, Alain ^a,c  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ DE ROUEN   (France)

^c INSERM INRS Universite de Rouen   (Canada)

Author keywords

Endocytosis; Intracellular receptor; Intracrine factor; Intranuclear calcium release; Pituitary adenylate cyclase activating polypeptide; Translocation

Indexed keywords

CALCIUM; CELL NUCLEUS RECEPTOR; CLATHRIN; FLUORESCEIN ISOTHIOCYANATE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CELL LEVEL; CELL NUCLEUS MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA SYNTHESIS; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TESTIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CALCIUM; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CELL SURVIVAL; CYTOSOL; ENDOCYTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN BINDING; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; TESTIS; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 84857665309     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.02.001     Document Type: Article

References (37)

1. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989, 164:567-574.
2. Miyata A., Jiang L., Dahl R.D., Kitada C., Kubo K., Fujino M., Minamino N., Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 1990, 170:643-648.
3. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K., Hashimoto H., Galas L., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 2009, 61:283-357.
4. Sherwood N.M., Krueckl S.L., McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 2000, 21:619-670.
5. Arimura A., Somogyvari-Vigh A., Miyata A., Mizuno K., Coy D.H., Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 1991, 129:2787-2789.
6. Vaudry D., Gonzalez B.J., Basille M., Pamantung T.F., Fournier A., Vaudry H. PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex. Ann. N. Y. Acad. Sci. 2000, 921:293-299.
7. Li M., Funahashi H., Mbikay M., Shioda S., Arimura A. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells. Endocrine 2004, 23:59-75.
8. Valdehita A., Bajo A.M., Fernandez-Martinez A.B., Arenas M.I., Vacas E., Valenzuela P., Ruiz-Villaespesa A., Prieto J.C., Carmena M.J. Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. Peptides 2010, 31:2035-2045.
9. Omary M.B., Kagnoff M.F. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line. Science 1987, 238:1578-1581.
10. Umetsu Y., Tenno T., Goda N., Shirakawa M., Ikegami T., Hiroaki H. Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments. Biochim. Biophys. Acta 2011, 1814:724-730.
11. Bourgault S., Vaudry D., Segalas-Milazzo I., Guilhaudis L., Couvineau A., Laburthe M., Vaudry H., Fournier A. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. J. Med. Chem. 2009, 52:3308-3316.
12. Trehin R., Nielsen H.M., Jahnke H.G., Krauss U., Beck-Sickinger A.G., Merkle H.P. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem. J. 2004, 382:945-956.
13. Lindgren M., Langel U. Classes and prediction of cell-penetrating peptides. Methods Mol. Biol. 2011, 683:3-19.
14. Jullian M., Hernandez A., Maurras A., Puget K., Amblard M., Martinez J., Subra G. N-terminus FITC labeling of peptides on solid support: the truth behind the spacer. Tetrahedron Lett. 2009, 50:260-263.
15. Doan N.D., Bourgault S., Dejda A., Letourneau M., Detheux M., Vaudry D., Vaudry H., Chatenet D., Fournier A. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochem. Pharmacol. 2011, 81:552-561.
16. Drin G., Cottin S., Blanc E., Rees A.R., Temsamani J. Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 2003, 278:31192-31201.
17. Jiao C.Y., Delaroche D., Burlina F., Alves I.D., Chassaing G., Sagan S. Translocation and endocytosis for cell-penetrating peptide internalization. J. Biol. Chem. 2009, 284:33957-33965.
18. Robberecht P., Gourlet P., De Neef P., Woussen-Colle M.C., Vandermeers-Piret M.C., Vandermeers A., Christophe J. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur. J. Biochem. 1992, 207:239-246.
19. Tominaga A., Sugawara H., Futagawa T., Inoue K., Sasaki K., Minamino N., Hatakeyama M., Handa H., Miyata A. Characterization of the testis-specific promoter region in the human pituitary adenylate cyclase-activating polypeptide (PACAP) gene. Genes Cells 2010, 15:595-606.
20. Inooka H., Ohtaki T., Kitahara O., Ikegami T., Endo S., Kitada C., Ogi K., Onda H., Fujino M., Shirakawa M. Conformation of a peptide ligand bound to its G-protein coupled receptor. Nat. Struct. Biol. 2001, 8:161-165.
21. Lyu R.M., Germano P.M., Choi J.K., Le S.V., Pisegna J.R. Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization. J. Biol. Chem. 2000, 275:36134-36142.
22. Madani F., Lindberg S., Langel U., Futaki S., Graslund A. Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys. 2011, 2011:414729.
23. Burton P.S., Conradi R.A., Hilgers A.R., Ho N.F.H., Maggiora L.L. The relationship between peptide structure and transport across epithelial-cell monolayers. J. Control. Release 1992, 19:87-97.
24. Sze K.H., Zhou H., Yang Y., He M., Jiang Y., Wong A.O. Pituitary adenylate cyclase-activating polypeptide (PACAP) as a growth hormone (GH)-releasing factor in grass carp: II. Solution structure of a brain-specific PACAP by nuclear magnetic resonance spectroscopy and functional studies on GH release and gene expression. Endocrinology 2007, 148:5042-5059.
25. Mao Y.K., Wang Y.F., Moogk C., Fox-Threlkeld J.E., Xiao Q., McDonald T.J., Daniel E.E. Locations and molecular forms of PACAP and sites and characteristics of PACAP receptors in canine ileum. Am. J. Physiol. 1998, 274:G217-G225.
26. Masmoudi-Kouki O., Douiri S., Hamdi Y., Kaddour H., Bahdoudi S., Vaudry D., Basille M., Leprince J., Fournier A., Vaudry H., Tonon M.C., Amri M. Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis. J. Neurochem. 2011, 117:403-411.
27. Yada T., Sakurada M., Ihida K., Nakata M., Murata F., Arimura A., Kikuchi M. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J. Biol. Chem. 1994, 269:1290-1293.
28. Winters S.J., Moore J.P. PACAP, an autocrine/paracrine regulator of gonadotrophs. Biol. Reprod. 2011, 84:844-850.
29. Cook J.L., Zhang Z., Re R.N. In vitro evidence for an intracellular site of angiotensin action. Circ. Res. 2001, 89:1138-1146.
30. Dennis M.K., Burai R., Ramesh C., Petrie W.K., Alcon S.N., Nayak T.K., Bologa C.G., Leitao A., Brailoiu E., Deliu E., Dun N.J., Sklar L.A., Hathaway H.J., Arterburn J.B., Oprea T.I., Prossnitz E.R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009, 5:421-427.
31. Jong Y.J., Kumar V., O'Malley K.L. Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts. J. Biol. Chem. 2009, 284:35827-35838.
32. Tadevosyan A., Maguy A., Villeneuve L.R., Babin J., Bonnefoy A., Allen B.G., Nattel S. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J. Biol. Chem. 2010, 285:22338-22349.
33. Vaniotis G., Del Duca D., Trieu P., Rohlicek C.V., Hebert T.E., Allen B.G. Nuclear beta-adrenergic receptors modulate gene expression in adult rat heart. Cell. Signal. 2011, 23:89-98.
34. Boivin B., Chevalier D., Villeneuve L.R., Rousseau E., Allen B.G. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J. Biol. Chem. 2003, 278:29153-29163.
35. Ko C., In Y.H., Park-Sarge O.K. Role of progesterone receptor activation in pituitary adenylate cyclase activating polypeptide gene expression in rat ovary. Endocrinology 1999, 140:5185-5194.
36. Li M., David C., Kikuta T., Somogyvari-Vigh A., Arimura A. Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38. J. Mol. Neurosci. 2005, 27:91-105.
37. Bootman M.D., Fearnley C., Smyrnias I., MacDonald F., Roderick H.L. An update on nuclear calcium signalling. J. Cell Sci. 2009, 122:2337-2350.